StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Regenerative Medical Technology's enterprise value was -$38.06M on Oct 19, 2026, against -$27.80M a year earlier. Over the last 5 years it ranged from -$38.06M to $16.37M, with a median of $31.73K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026-$38.06M-332.5%
2025Dec 31, 2025$16.37M–
2024Dec 31, 2024-$479.07K–
2023Dec 29, 2023-$1.03M-108.9%
2022Dec 30, 2022$11.56M–
2021Dec 31, 2021-$7.75M-3044.6%
2020Dec 31, 2020$263.04K+151.1%
2019Dec 31, 2019$104.78K-40.1%
2018Dec 31, 2018$174.91K–

More Regenerative Medical Technology figures

See a number that looks wrong?